Back to search
FDAFDA · Food and drugs·Recall number Z-0977-2013

BS-200 Chemistry Analyzer Designed for clinical laboratory use.

Published April 3, 2013 · Recall initiated: November 28, 2012

Summary

FDA records medical device Class II recall Z-0977-2013, published April 3, 2013 and initiated November 28, 2012. Recalling firm: Mindray DS USA, Inc. d.b.a. Mindray North America; Status: Terminated; Reported quantity: 3 units; Lot: Part number BA20E-PA00003; Serial Numbers: WN-28103978F, WN-28103976F, and WN-28103977F. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

An issue has been identified with the BS-200 where clinical chemistry results may be inaccurate.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mindray DS USA, Inc. d.b.a. Mindray North America
Distributor
Distributed in the states of NC and TX.
Lot
Part number BA20E-PA00003; Serial Numbers: WN-28103978F, WN-28103976F, and WN-28103977F.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BS-200 Chemistry Analyzer Designed for clinical laboratory use. recalled?

Yes. FDA published recall Z-0977-2013 on April 3, 2013. Reported hazard: An issue has been identified with the BS-200 where clinical chemistry results may be inaccurate.

What should I do if I have this product?

Voluntary: Firm initiated · Letter